Recent evidence established that the cell envelope of Mycobacterium tuberculosis, the bacillus causing tuberculosis (TB), is coated by an α-glucan-containing capsule that has been implicated in persistence in a mouse infection model. As one of three known metabolic routes to α-glucan in mycobacteria, the cytoplasmic GlgE-pathway converts trehalose to α(1 → 4),α(1 → 6)-linked glucan in 4 steps. Whether individual reaction steps, catalyzed by trehalose synthase TreS, maltokinase Pep2, and glycosyltransferases GlgE and GlgB, occur independently or in a coordinated fashion is not known. Here, we report the crystal structure of M. tuberculosis TreS, and show by small-angle X-ray scattering and analytical ultracentrifugation that TreS forms tetramers in solution. Together with Pep2, TreS forms a hetero-octameric complex, and we demonstrate that complex formation markedly accelerates maltokinase activity of Pep2. Thus, complex formation may act as part of a regulatory mechanism of the GlgE pathway, which overall must avoid accumulation of toxic pathway intermediates, such as maltose-1phosphate, and optimize the use of scarce nutrients.
■ INTRODUCTION
The cell envelope of Mycobacterium tuberculosis, the organism causing tuberculosis (TB), remains a central focus of TB research. It contributes critically to virulence and survival in the host, yet our understanding of how its complex architecture is assembled is fragmentary. Pathways of cell wall synthesis continue to be scrutinized for potential novel therapeutic targets, which are urgently needed to help ease the burden of the global TB epidemic and the threat posed by rising antibiotic resistance. 1−3 Evidence from cryo-electron microscopy has recently confirmed that mycobacteria are coated by a capsular layer. 4 The capsular layer is composed of α-glucan (80−90%), arabinomannan (10−20%), and proteins of the ESX-1 secretion system, 4 and could offer novel serological biomarkers for TB infection. 5 The dominant component of the capsular layer, αglucan, is a polymer composed of α(1 → 4)-linked glucose units with α(1 → 6)-branching. To date, three metabolic pathways in mycobacteria are known to synthesize α-glucan (at least as an intermediate) including the classical GlgC−GlgA pathway, the Rv3032 pathway, and the GlgE pathway. These pathways share common nodes or are linked by synthetic lethal interactions. 6, 7 Although the α-glucan capsule is shed readily in detergent-containing liquid cultures, a knockout of GlgA compromised persistence of tubercle bacilli in a mouse infection model, suggesting that persistence requires an intact capsule. 8 However, the extent to which the three pathways contribute to the synthesis of capsular α-glucan remains to be established. In the recently discovered 4-step GlgE pathway 7, 9 (Figure 1 ), the starting material is trehalose (α,α-1,1-diglucose), which is isomerized to maltose (α,α-1,4-diglucose), in a step catalyzed by M. tuberculosis trehalose synthase, TreS, followed by phosphorylation of maltose to maltose-1-phosphate, catalyzed by maltokinase Pep2. The phospho-activated disaccharide is then incorporated into the growing α-(1 → 4)-glucan chain by glycosyltransferase GlgE, while glycosyltransferase GlgB mediates α(1 → 6)-branching of the chain. 7, 10 Mycobacteria can generate trehalose, a carbohydrate store and stress protectant, from cytosolic glycogen by the TreX−TreY− TreZ pathway or from glucose-1-phosphate via GalU and OtsA−OtsB. 6 In addition, trehalose can be recycled between the cell wall and the cytoplasm by an ABC transporter system that is essential for virulence. 11 Such metabolic networks ensure that M. tuberculosis makes optimal use of scarce carbohydrates, a major limitation of its ecological niche.
Classical and reverse genetics have shown that both glgE and glgB are essential genes, while simultaneous inactivation of the treS gene recovered viability. In contrast, the ΔtreS deletion on its own had no effect on growth. 7 This phenotypic pattern was interpreted as the consequence of self-poisoning by the toxic pathway intermediate maltose-1-phosphate, as the latter is produced (by TreS and Pep2), but not processed further. Limitations of nutrient supply and synthesis of toxic pathway intermediates suggest that α-glucan synthesis is subject to regulatory control. To date we do not know what mechanisms regulate α-glucan synthesis nor whether enzymes of the GlgE pathway work independently or in a coordinated fashion.
Here, we report structural, biophysical, and biochemical evidence demonstrating that formation of a large multicatalytic complex of TreS and Pep2 affects enzymatic activity of the latter, suggesting that complex formation may be part of a regulatory mechanism of the GlgE pathway.
■ RESULTS AND DISCUSSION X-ray Crystal Structure of TreS. The structure of M. tuberculosis TreS was solved by molecular replacement to a resolution of 2.6 Å (Figure 2A,B) . The asymmetric unit of the crystal lattice contains two copies of TreS (chains A and B), which were refined using noncrystallographic symmetry restraints. As a result, the two copies of TreS superimpose closely with a root-mean-square deviation (rmsd) of 0.6 Å for 537 paired carbon-α (Cα) positions. The electron density covers residues 12 to 586 (of 601 amino acids total), whereby the uncleaved N-terminal affinity-tag, as well as residues 1−11 and residues 587−601 are disordered. In addition, density is poor or absent for residues 426−429 in chain A and residues 353−381 in chain B.
By sequence similarity, TreS belongs to family GH13 of glycoside hydrolases (www.cazy.org). 12 The prototypic structures of this large enzyme family comprise two conserved domains: a catalytic domain with a (β/α) 8 barrel-like fold (known as the triosephosphate isomerase or TIM barrel fold), and a C-terminal β-sandwich domain (Figures 2A,B and S1A, Supporting Information). The closest structural neighbor according to distance matrix alignment (DALI 13 ) is Neisseria polysaccharea amylosucrase (PDB entry 1ZS2, 14 27% sequence identity), aligning with an rmsd of 2.7 Å over 492 aligned Cα positions ( Figure 3A ). The core TIM barrel is decorated with extended loops, for some of which specific functional roles are discernible (Figure S1A, Supporting Information). For instance, the β3-β4 loop contains a calcium binding site, close to the active site but of unknown mechanistic significance ( Figures  2A,B and S1B, Supporting Information). The β7−β8 loop folds over the central β-barrel in chain A but is disordered in chain B for residues 353−381, while the β6−β7 loop includes a helixturn-helix motif that replaces the canonical helix α6 of the TIMbarrel fold.
The Ca 2+ ion is octahedrally coordinated by Oδ1 of Asp208 and the carbonyl oxygen of Leu243 at the apexes and Asp140 and Glu245, a water molecule and the carbonyl oxygen of Tyr242 in the central plane of the octahedron ( Figure S1B , Supporting Information). The identity of this site as calcium is supported by strong anomalous density (7.4σ above background, calculated with diffraction data recorded at 1.77 Å; Figure S1B , Supporting Information) and the overlap with a corresponding Ca 2+ site in a structural neighbor (α-amylase SusG of Bacteroides thetaiotaomicrometer, 3K8K). 15 Analysis of packing interfaces (PISA, 16 www.ebi.ac.uk/msdsrv/prot_int/pistart.html) suggested that TreS may form tetramers in solution (2TreS A + 2TreS B , Figure 2C ), with an extensive buried solvent-accessible surface of ∼11 000 Å 2 . When testing self-assembly by analytical ultracentrifugation, a tetrameric species was found (see below). Intersubunit contacts are primarily mediated by the C-terminal β-sandwich domain, the Ca 2+ -binding β3−β4 loop, and at the center of the tetramer, by the β8−α8 loop ( Figure 2C ).
ACS Chemical Biology
Differential Ordering of β7−β8 Loop in the Active Site. A recent mechanistic study has identified the catalytic residues of TreS in the closely related (83% identity) M. smegmatis species, 17 which correspond to Asp238 (nucleophile), Glu280 (general acid), and Asp350 (unknown function) in M. tuberculosis. These residues are situated at the top (Cterminal) rim of the β-barrel ( Figure 3A ). By soaking and cocrystallization, we sought unsuccessfully to generate substrate/product-bound complexes of TreS. The structure contains several bound sulfate ions, including one in each of the active site of chains A and B ( Figure S1C , Supporting Information). High sulfate concentrations were critical to grow crystals of TreS and to maintain crystal stability during soaking, promoting sulfate binding in the active site ( Figure S1C , Supporting Information), which may interfere with substrate binding.
Superimposing chain A of TreS with sucrose-bound structures of amylosucrase (PDB entry 1ZS2 14 ) or trehalulose synthase (2PWE 18 ) shows that the β7−β8 loop, containing the catalytic Asp350, overlaps with the position of the substrate ( Figure 3B ). Indeed, in sucrose-bound amylosucrase, the β7−β8 loop is in a markedly different conformation, with the aspartic acid corresponding to Asp350 (Asp393) shifted away by 3.8 Å from the substrate-binding site and forming H-bonds with the glucosyl moiety of the sugar. In chain B of TreS, density for the β7−β8 loop (at a 1σ contour level) is invisible for residues 353−381, despite the bound active site sulfate, suggesting inherent flexibility of this loop.
The crystal tetramer of TreS possesses two 2-fold rotational symmetry axes, mapping subunit A onto subunit A′ and B onto B′ (by crystallographic symmetry), and chain A onto chain B (A′ onto B′, by the noncrystallographic 2-fold rotation) ( Figures 2C and 3C ). The active sites of each noncrystallographic pair of subunits (A−B and A′−B′) are connected by an internal cavity or tunnel, and the substrate binding sites are separated by about 35 Å. In a state where the β7−β8-loop is disordered (as is the case for chain B), the active site is wide open to solvent ( Figure 3D ). Yet even when this loop ordered the active site remains solvent-accessible.
TreS-catalyzed isomerization of trehalose to maltose proceeds through a double displacement mechanism, which involves a covalently bound glucosyl-enzyme intermediate. 17 Such mechanism raises the question whether, between glycosylation and deglycosylation of TreS, the leaving group (the noncovalently bound glucose molecule) diffuses out of the active sit or is retained, reorients, and reattacks the covalently bound half of the disaccharide. Recent evidence using 13 Clabeled glucose in addition to unlabeled disaccharide indicated that no labeled glucose was incorporated into the product, strongly suggesting that isomerization occurs without release of the leaving glucose molecule to solvent. 17 Hydrolysis of trehalose (and maltose) to glucose occurs as a side reaction (see below), suggesting that retention of the leaving glucose molecule is imperfect. Nonetheless, the ordered vs disordered state of the β7−β8 loop in chains A and B, respectively, may be linked to enabling retention of the hydrolyzed substrate in the active site.
In the conformation of chain A, the β7−β8 loop overlaps with the substrate binding site ( Figure 3B ), but relatively minor structural adjustments of this loop suffice to make space for a disaccharide. It is conceivable that the loop acts as a clamp, helping to hinder diffusion of the leaving glucose out of the active site. Of the three catalytic carboxylic acids (Asp238, Glu280, and Asp350), 17 Asp350 is located in the β7−β8 loop. Furthermore, in this loop, residues 350 to 366 are strictly conserved in mycobacteria, and only two conservative substitutions (Ser to Thr and Asp to Ser) occur in TreS of Corynebacterium glutamicum, a nonpathogenic surrogate organism. Sequence conservation could provide conserved, specificity-determining contacts with the noncovalently bound glucose. At the same time, conformational flexibility could provide plasticity required to facilitate the reorientation of the cleaved glucose moiety, together favoring reorientation of the leaving glucose over release from the active site. Very recently a crystal structure M. smegmatis TreS was determined, with structural features consistent to our findings. 19 Solution X-ray Scattering of TreS. Crystal packing interfaces had suggested that TreS assembles as a tetramer in solution. We wondered whether this apparent tetramer (the "crystal tetramer") described how TreS assembles in solution and probed self-assembly of TreS by small-angle X-ray scattering (SAXS). Guinier plot analysis (PRIMUS 20 ) confirmed that TreS does not aggregate in the solution state, with a radius of gyration of R g = 4.71 nm ( Figure S2A , Supporting Information). The distance distribution function is approximately bell-shaped, indicative of a globular protein ( Figure S2B , Supporting Information). We next calculated theoretical scattering curves based on the crystal structure of TreS using CRYSOL, 21 assuming monomeric, dimeric, and tetrameric configurations. Pronounced deviations from the experimental data are evident at low scattering angles for calculated curves assuming a monomer or dimer. In contrast, the tetrameric configuration was able to reproduce the features of the measured scattering curve at low scattering angles ( Figure 4A ), although systematic deviations are still apparent at s ≥ 0.1 nm −1 . The discrepancy indicates that the arrangement of the subunits in the solution tetramer may differ from that in the crystal tetramer, likely reflecting the absence of packing constraints imposed in the lattice. Nevertheless, a bead model calculated solely on the basis of the scattering curve (DAMMIF 22 and DAMAVER 23 ) envelops the crystal tetramer and shows internal features compatible with the tetrameric structure ( Figure 4B ).
Thus, the solution scattering data indicate that the TreS tetramer observed in the crystal lattice describes the assembly in the solution state, although the SAXS-derived molecular envelope, derived without assuming internal symmetry, suggests that the solution tetramer is not strictly symmetrical.
TreS and Pep2 Form a Noncovalent Complex. In the genome of M. tuberculosis, TreS and Pep2 are encoded by separate genes (Rv0126 and Rv0127, respectively), but they appear as a gene fusion in a considerable number of bacterial species. 6 We, therefore, investigated whether TreS and Pep2 form a noncovalent complex. First, we examined elution of TreS and Pep2 from a size exclusion resin. Calibration of the resin using bovine serum albumin (BSA) showed a dominant monomer peak at 137 mL (66.5 kDa) and a weaker dimer peak at 116 mL (133 kDa), consistent with published data. 24 Trehalose synthase (monomer mass 72 kDa) on its own eluted with a dominant peak at 107 mL ( Figure S3A , Supporting Information), while M. tuberculosis Pep2 (monomer mass 52 kDa) showed a continuous size distribution with three distinct peaks at 108, 114, and 149 mL. Compared to the BSA standard, these peaks could represent tetrameric, trimeric, and monomeric assembly states of Pep2, respectively. Analyzing the elution of a mixture of TreS with Pep2 (nominal molar ratio of 1:2) resulted in a dominant peak at 98 mL, over a background of a size distribution that resembled that of Pep2 alone.
Analyzing the elution fractions by denaturing polyacrylamide gel electrophoresis (SDS-PAGE; Figure S3B , Supporting Information) demonstrates that the peak at 98 mL includes TreS and Pep2 in approximately equal parts (by visual inspection of band intensity), whereas on its own, Pep2 starts eluting from the column only at 105 mL, with the peak fractions eluting between 110 and 115 mL. Thus, TreS and Pep2 coelute and do so earlier than on their own, strongly suggesting complex formation.
Stoichiometry of the TreS:Pep2 Complex. Next, we analyzed the sedimentation behavior of TreS and Pep2 by analytical ultracentrifugation. In the absence of Pep2, TreS sediments at a sedimentation coefficient of 11S, with a much smaller maximum at 16S ( Figure 5A ). Fitting a single frictional coefficient, these two peaks correspond to molecular masses of 260 000 and 470 000, respectively, indicating that TreS exists predominantly as a tetramer in solution (monomer mass of TreS is 72 kDa), with only a weak tendency of forming higher oligomers. The fact that two peaks are seen is indicative that the exchange between the tetramer and octamer is slow on the time scale of sedimentation (ca. 10 −5 s −1 ). No evidence of a TreS monomer or dimer was found in this velocity experiment or the size exclusion profile. When analyzed on its own, Pep2 displays maxima at sedimentation coefficients of 3.8S and 8.9S, corresponding to molecular masses of 54 000 and 188 000, respectively. Compared to the calculated mass of recombinant Pep2 (52 kDa), the 3.8S peaks represents a Pep2 monomer, while the 8.9S peak could represent a mixture of Pep2 trimers and tetramers, which were both apparent in the size exclusion profile of Pep2.
Adding Pep2 to TreS in molar ratios of 0.25:1, 0.5:1, 1:1, 2:1, and 4:1 (with respect to monomers), distinctly altered the c(s) distribution profile. The peak at 11S, representing the TreS tetramer, shifted continually to about 13.1S until the molar ratio was 2:1, and changed only slowly thereafter (Figure 5A + inset). Within in the limits of the resolution of the c(s) distribution, the profiles indicated a continuous shift of the original 11S peak, rather than this peak disappearing and a new peak (at 13.1S) appearing instead. Thus, the c(s) distributions suggest that Pep2 gradually associates with the tetramer of TreS in a fast exchange on the time scale of sedimentation. The shifted TreS peak (13.1S) at a 4:1 ratio of Pep2:TreS corresponds to 345 kDa, fitted with a single frictional ratio. This mass would be compatible with four TreS plus two Pep2 subunits. However, fitting only a single frictional ratio, which varied between 1.11 and 1.48 ( Figure S4A , Supporting Information), for a complex mixture of species, significant over-or underestimates of actual masses are possible. Therefore, we performed an analysis of the TreS:Pep2 complex by analytical ultracentrifugation in sedimentation equilibrium Assuming that only a single species (the TreS:Pep2 complex) is present and fitting its molecular weight yielded an experimental mass of 452 861 Da [±4670 Da] (global fit over data from three speeds and three sample concentrations), but still led to systematic deviations in the residual plots. In contrast, a model of 2 noninteracting species in which Pep2 (present at a 2:1 molar ratio to TreS) was assumed to remain monomeric when not part of the TreS:Pep2 complex, led to a fitted mass of 506 101 Da [±9975 Da] (global fit) for the complex, with residuals showing no systematic deviation (Figure s5B , S4B, and S4C, Supporting Information). Thus, the fitted mass of the TreS:Pep2 complex is most compatible with a complex of TreS tetramer bound to four Pep2 subunits (calculated mass 491 000).
Pep2 Activity Varies in the Presence of TreS in a Dose-Dependent Fashion. Initially, we probed activities of recombinant trehalose synthase and maltokinase in an endpoint assay, monitoring reaction products by thin layer chromatography. 7 Incubation of TreS with trehalose or maltose interconverted the substrates (Figure S5A , Supporting Information), as reported previously for M. smegmatis TreS. 25 At high enzyme concentrations, we also observed the hydrolysis of the disaccharide to glucose, as reported for M. smegmatis TreS. 17, 25 Incubating trehalose with both TreS and Pep2 produces maltose-1-phosphate ( Figure 6A, lanes 11−13) . Phosphorylation of maltose is ATP-dependent ( Figure 6A , lane 8), consistent with previous evidence, 26 but Pep2 does not phosphorylate trehalose under the assay conditions ( Figure 6A , lane 6). Likewise, TreS does not produce a phosphorylated sugar when incubated with either trehalose or maltose ( Figure  6A, lanes 4 and 5) . Thus, the 2-step conversion from trehalose to maltose-1-phosphate occurs only when both enzymes, TreS and Pep2, are present.
We then asked whether complex formation between TreS and Pep2 affects the catalytic activity of the constituent enzymes. To this end, we designed a continuous enzyme assay that quantified Pep2-catalyzed phosphorylation of maltose by coupling ATP-to-ADP conversion to oxidation of NADH, monitoring the latter fluorimetrically. Varying maltose at a fixed initial ATP concentration or varying ATP at a fixed initial maltose concentration resulted in Michaelis−Menten type kinetics in both cases (Figures 6B,C) . Fixing ATP at 0.5 mM and increasing the concentration of TreS (from nil to a molar ratio of 4 TreS to 1 Pep2) tripled V max in a nearly linear fashion ( Figures 6C and S5B , Supporting Information; Table 2 ). In contrast, K M increased moderately from the TreS-free to the TreS:Pep2 complex state, after which any change remained within the experimental error ( Figure S5C , Supporting Information; Table 2 ). Varying ATP at a fixed maltose concentration (20 mM) mirrored this pattern in that V max even quadrupled, while the K M for ATP increased when TreS was added, but remained invariant within error for [TreS]/ [Pep2] ratios ≥ 1 (Figures 6C, S5B , and S5C, Supporting Information; Table 2 ). This effect was protein-specific: adding bovine serum albumin (BSA) to Pep2 at the same molar ratios resulted in changes of activity that were nonsystematic and distinctly smaller in magnitude (±30%; Figure S5D , Supporting Information), underscoring that the pronounced and dosedependent increase of V max of Pep2 was specific for TreS, likely a consequence of complex formation.
In order to test whether complex formation also affected the activity of TreS, we monitored M. smegmatis TreS-catalyzed conversion of trehalose to glucose in an enzyme-coupled continuous assay (see Methods). Since the coupling reactions involved conversion of ATP to ADP, it was necessary to rule out ATP depletion by Pep2-catalyzed conversion of maltose to maltose-1-phosphate. We designed three point mutants of M. smegmatis Pep2 (K145A, Q309A, and D321A) aiming to abrogate ATP binding. Two of these mutants (K145A and D321A) showed activity levels that were indistinguishable from the baseline of the assay (Figure S6A , Supporting Information). We chose the Pep2-K145A mutant for further experimentation, verifying by size exclusion chromatography that this mutant still formed a complex with TreS ( Figure S6B , Supporting Information). Because of trace contaminations of glucose in the substrate, we were limited to probing activity at trehalose concentrations of less than half the K M (∼85 mM). 17 We, therefore, compared the slopes Figures 6D and S6C , Supporting Information). We conclude that complex formation increases Pep2 activity markedly, but affects TreS activity to a far lesser extent. Evidence for TreS:Pep2 Complex Formation in Vivo. In order to probe whether TreS and Pep2 form a complex in vivo, we overexpressed and purified His 6 -tagged M. smegmatis Pep2 from cell extracts of Mycobacterium smegmatis mc 2 155 using Ni-NTA and ion exchange chromatography. To detect endogenous TreS, we analyzed column fractions for their ability to convert trehalose to maltose-1-phosphate, which requires the presence of both TreS and Pep2. As the purification involved two successive chromatography steps, in which the Ni-NTA matrix selected for the His-tagged Pep2, observation of TreS activity indicated complex formation. Coomassie-staining failed to visualize endogenous TreS enzyme on the SDS gel of the untreated column fractions ( Figure 7A, main panel) , but thinlayer chromatography showed fraction-specific conversion of trehalose to maltose-1-phosphate ( Figure 7B ). Concentrating 

■ CONCLUSIONS AND FINAL REMARKS
To our knowledge, complex formation between TreS and Pep2 in mycobacteria has not been reported previously but is perhaps not surprising given the treS-pep2 gene fusion in a considerable number of bacterial species. 6 Yet the size of this complex (a hetero-octamer of ∼0.5 × 10 6 Da) is unexpected. A survey of structural neighbors of TreS (according to analyses of crystal packing interfaces) suggests that monomeric and dimeric biological assemblies prevail by far. Our data indicate that the TreS-Pep2 hetero-octamer is built on the platform of a TreS tetramer. On the basis of size exclusion chromatography, a hexameric assembly has previously been reported for M. smegmatis TreS. 25 However, size exclusion, in a strict sense, sizes on hydrodynamic radii rather than mass; hence, accurate mass estimates are difficult to obtain. In contrast, our analytical ultracentrifugation and SAXS data clearly indicate a tetramer as the preferred assembly state of TreS in solution. The shift of the dominant TreS tetramer peak to higher S-values in the c(s) profile on adding Pep2 indicates that Pep2 subunits bind to the TreS tetramer, as opposed to the TreS tetramer dissociating and reassembling into a TreS:Pep2 octameric complex. The complex appears to be in equilibrium between the octameric state and a state of free Pep2 and free TreS tetramer, as including free Pep2 in the model removed systematic deviations between data and fit. Excess of one or the other partner appears to be required to reach a saturated complex, which is also consistent with the influence of TreS on Pep2 activity. Complex formation with TreS significantly upregulates the activity of Pep2, an effect that is not explained by nonspecific protein−protein interactions, as the BSA control demonstrates. While activity of TreS also increases in response to complex formation, the effect is subtle by comparison. In the absence of a structure for Pep2 (or the Pep2:TreS complex), the mechanistic basis of the 3-fold (maltose) or 4-fold (ATP) increase of V max is not obvious, but complex formation might drive Pep2 into a conformation that favors catalysis by reducing the sampling of conformational states that are compatible with substrate binding but do not allow turnover.
A key requirement during α-glucan synthesis is to avoid accumulation of toxic pathway intermediates. Stress by increased levels of maltose-1-phosphate appears to result in inhibition of respiration and the induction of the SOS regulon, which controls the DNA damage response. 7 Complex formation would be an effective strategy to direct the flow of pathway intermediates through consecutive catalytic steps. The open active site of the TreS tetramer and the tunnel between the active sites within the TreS tetramer would offer several mechanistic options for docking of partner enzymes and the efficient transfer of pathway intermediates. Thus, our study provides a first hint to the intriguing possibility of the GlgE pathway being organized as a multicatalytic machinery that controls the flow of pathway intermediates by complexation between pathway enzymes.
■ METHODS Recombinant Proteins. The genes of M. tuberculosis trehalose synthase treS (Rv0126) and pep2 (Rv0127) were amplified by polymerase chain reaction (PCR, primers in Table S1 , Supporting Information) from M. tuberculosis H37Rv genomic DNA. The PCR products were ligated into NdeI and HindIII sites of plasmid pET28a (Novagen). E. coli BL21 (DE3) cells were heat-transformed with plasmids, encoding either TreS or Pep2, and cultured on agar plates (LB/kanamycin 25 μg/mL). A single colony was used to inoculate 10 mL of LB broth, 1% (w/v) glucose, and kanamycin (25 μg/mL), followed by incubation overnight (37°C). The liquid culture was centrifuged and resuspended in fresh Terrific Broth media (TB 27 ) with kanamycin (50 μg/mL), and incubated at 37°C (200 rpm). At OD 600 = 0.4, the cultures cooled to 16°C for 3 h, and protein expression was induced using 1 mM IPTG (TreS) or 0.1 mM IPTG (Pep2), followed by further incubation (21 h, 16°C, 200 rpm) . Cells were harvested (7000g, 10 min), washed with phosphate buffered saline (PBS), resuspended in 30 mL lysis buffer (25 mM HEPES-NaOH pH 7.6, 1 M NaCl, 20% (v/v) glycerol), and frozen at −80°C until further use.
Protease inhibitor cocktail (Roche), 1 mM PMSF, 10 mM MgCl 2 , and 10 μg/mL DNase I were added to the resuspended cell pellet, which was passed 4 times through a French Press (Thermo Spectronic FA-078). The cleared lysate (27,000g, 30 min, 4°C), was diluted 4fold with buffer A (25 mM HEPES-NaOH pH 7.6, 1 M NaCl, 10% (v/ v) glycerol), filtered (0.45 μm pore size), and loaded on a preequilibrated Ni-NTA column (5 mL, GE Healthcare). The column was washed with buffer A (5 column volumes), and buffer A + 20 mM, 40 mM, and 60 mM imidazole, respectively. The protein was eluted with 500 mM imidazole in buffer A, and fractions were analyzed by SDS-PAGE. The eluate was diluted 20-fold with buffer B (20 mM Bis-Tris pH 6.5), filtered (0.45 μm), and applied on a HiTrap Q-column (1 mL, GE Healthcare Life Sciences) pre-equilibrated with 20 mM Bis-Tris pH 6.5 and 50 mM NaCl. The column was washed with buffer B supplemented with NaCl (50 to 500 mM, steps of 50 mM). Fractions were analyzed by SDS-PAGE and pooled, followed by concentration in Amicon Ultra-4 centrifugal filter units, then loaded on a HiPrep Sephacryl 26/60 S-200HR column (GE Healthcare). Fractions containing protein were concentrated as described before.
Crystallization and Structure Determination. Crystals of TreS were grown by vapor diffusion in 96-well plates, using a Mosquito liquid handling system (TTP Labtech) to set up crystallization drops containing 100 nL of TreS (80 mg mL -1 ) + 100 nL of reservoir solution. Sizable crystals grew over a reservoir of 0.1 M sodium citrate pH 5.6, 0.5 M (NH 4 ) 2 SO 4 , and 1 M Li 2 SO 4 . Crystals were soaked in mother liquor supplemented with either 15% (v/v) glycerol or 100 mM maltose or both, and frozen in liquid nitrogen. Diffraction data were recorded from a single crystal on beamline I04 (Diamond Light Source, Table 1 ). Data were processed and scaled (XDS and XSCALE 28 ) and the structure phased by molecular replacement (PHASER 29 ) using an ensemble of aligned search models (PDB entries 2ZE0, 30 1UOK, 31 2PWE, 18 1WZA 32 ), truncating nonconserved side chains (CHAINSAW 33 ). Using 2-fold noncrystallographic symmetry averaging of the MR-phased map led to interpretable density, and the model was completed through iterative rounds of building and refinement (COOT 34 and REFMAC5 35 ).
Small Angle X-ray Scattering. Solution scattering data of TreS (concentration range 8.1 to 2.3 mg mL −1 ) were recorded on beamline BM29 at ESRF, Grenoble. The protein was buffered in 20 mM Bis-Tris pH 6.5, 150 mM NaCl, and the sample cell equilibrated at 20°C. Exposures comprised 10 frames exposed for 2 s each in flow mode, which were merged. The detector images were integrated and reduced to 1-dimensional scattering curves, and buffer contributions to scattering were subtracted using the beamline software BsxCuBE. Scattering curves were displayed using the program PRIMUS. 20 All SAXS data analyses were performed using programs of the ATSAS suite version 2.5 (www.embl-hamburg.de/biosaxs/software.html).
Size Exclusion Chromatography. The elution of TreS and Pep2, a 2:1 molar mixture of Pep2:TreS from a Sephacryl S-200HR resin (320 mL column volume), was monitored by UV absorbance at 280 nm with a flow rate of 0.5 mL/min, and fractions (5 mL) were analyzed by SDS-PAGE. Proteins were in 20 mM Bis-Tris pH 6.5, 150 mM NaCl. Analytical Ultracentrifugation. Sedimentation velocity and equilibrium experiments used a Beckman Optima XL-A analytical ultracentrifuge equipped with absorbance optics. Protein samples were dialyzed into 20 mM Bis-Tris pH 6.5, 150 mM NaCl, and, for the velocity experiments, loaded into cells with 2-channel Epon centerpieces and quartz windows. A total of 120 absorbance scans (280 nm) were recorded (25 000 rpm, 20°C) for each sample, representing the full extent of sedimentation of the sample. Data analysis was performed using SEDFIT, fitting a single frictional ratio ( Figure  S4A , Supporting Information). 36 The sedimentation equilibrium experiment (96 h total duration) was conducted at a rotor temperature of 4°C. Samples buffered as above were loaded into 6-channel Epon centerpieces with quartz windows, and data were recorded at 6000, 7000, and 8000 rpm, respectively, at three different sample concentrations (see captions of Figures 5 and S4 , Supporting Information). At each rotation speed, the sample was allowed to reach equilibrium during a 24 h period. The data analysis was performed using SEDPHAT. 37 Parameters for solvent density and viscosity and for the partial specific volume (v ̅ p ) of the proteins were calculated using SEDNTERP (sednterp.unh.edu).
ACS Chemical Biology
Overexpression of Pep2 in M. smegmatis. DNA primers (Table S1, Supporting Information) were obtained from MWG, and DNA of the M. smegmatis pep2 gene was amplified by PCR. The purified PCR fragment (Qiagen) was ligated into the pSD26 plasmid (BamH1 and EcoRV), which was transformed into M. smegmatis mc 2 155 cells by electroporation. Cells were selected on LB/hygB + (50 μg/mL) agar plates, and a single colony was used to inoculate a 3 mL culture (LB/hygB + at 50 μg/mL + 0.05% Tween-80) and grown for 2 d at 37°C. The culture was propagated (1% v/v inoculation) into 50 mL (2 d growth) and 1 L, grown to midlog phase, induced with 0.2% w/v acetamide, and incubated overnight (16°C). Cells were harvested (7000g, 10 min, 4°C), resuspended in 25 mM Hepes-NaOH, pH 7.5, 300 mM NaCl, 10% v/v glycerol, 1 mM β-mercaptoethanol, 10 mM MgSO 4 , DNase, and lysozyme, and lysed by sonication (12 cycles of 60 s on, 90 s off at maximum amplitude). The lysate was cleared (27 000g, 30 min, 4°C), the supernatant filtered (0.45 μm) and loaded on a pre-equilibrated Ni-NTA HiTrap HP column (GE Life Science, 5 mL) and washed with buffer A (25 mM Hepes-NaOH, pH 7.5, 300 mM NaCl, 10% v/v/glycerol) adding imidazole in steps of 20, 40, 60, 80, 100, 150, 200, 250, 300, and 500 mM (5 column volumes per step). Protein containing fractions were analyzed by SDS-PAGE, pooled, and diluted 6-fold into buffer B (20 mM Bis-Tris pH 6.0, 10% glycerol) prior to loading on an anion exchange column (HiTrap QHP, 1 mL, GE Life Science). Protein was eluted with a stepwise NaCl gradient ( Figure 7A ).
Generation of Inactive Pep2 Mutants. A structural model for Pep2 was generated using the fold prediction server Phyre2 (http:// www.sbg.bio.ic.ac.uk/phyre2) 38 based on the sequence of M. smegmatis Pep2. Comparison with ATP-bound structural homologues suggested three residues (K145, Q309, and D321) as critical for Mg 2+ and/or ATP binding. Individual point mutations to alanine were introduced into the pep2 gene of M. smegmatis using the Quikchange approach (Stratagene, primers in Table S1 , Supporting Information). The His 6tagged proteins were expressed and purified as described for wild-type Pep2. Activity of the mutants was tested with the assay described below ( Figure S6A , Supporting Information).
End Point Assays Probing Trehalose Synthase and Maltokinase Activity. Reaction mixtures probing TreS activity were in a final volume of 100 μL, containing 50 mM HEPES-KOH buffer (pH 7.5), 100 mM maltose or trehalose, and TreS. Reaction mixtures probing maltokinase activity (100 μL) consisted of 50 mM HEPES-KOH buffer, pH 7.5, 10 mM MgCl 2 , 5 mM ATP, and 560 nM Pep2 and were initiated by the addition of 100 mM maltose. All reactions were at 37°C for 1 h and stopped by adding an equal volume of ice-cold acetone, followed by centrifugation (20 000g, 4°C, 10 min). The supernatant was transferred and dried by speedvac (Hetovac). To discriminate trehalose from maltose, the dried reaction product was dissolved in 200 μL water and 2 μL of the solution applied on silica gel concentrating zone HPTLC plate (Merck, Darmstadt, Germany) and developed in the solvent system butanol/ pyridine/water (7:3:1 v/v/v). In order to detect phosphorylated reaction products ( Figures 6A and 7B) , maltose-1-phosphate was separated from maltose using aluminum backed silica gel 60 F 254 TLC plates (Merck, Darmstadt, Germany), using the solvent system butanol/ethanol/water (5:3:2 v/v/v), developing the plate three times in the same solvent system. Conversion of trehalose to maltose-1-phosphate was probed by incubating both TreS (140 nM) and Pep2 (0, 35, 70, and 140 nM) in a reaction mixture (50 mM HEPES-KOH buffer, pH 7.5, 10 mM MgCl 2 , 5 mM ATP) and initiating turnover with 100 mM trehalose as substrate. To visualize the products, the dried TLC plates were sprayed with α-naphthol sulfuric acid stain, followed by mild charring with a heat gun.
Continuous Assay. In order to monitor phosphorylation of maltose, conversion of ATP to ADP was enzymatically coupled to oxidation of NADH (via pyruvate kinase and lactate dehydrogenase), and the latter monitored fluorimetrically (excitation 340 nm and emission 450 nm). Fluorescence units were converted to concentrations of ADP by an internal calibration curve for NADH. The assays were performed in triplicate in 96-well plates, using a BMG PHERAstar FS microtiter plate reader and MARS and GraphPad Prism software to record and analyze data, respectively.
Reaction mixtures contained 50 mM HEPES-NaOH (pH 7.5), 50 mM NaCl, 10 mM MgCl 2 , and Pep2 at 0.2 μM (when varying ATP) or 1.2 μM (when varying maltose), adding TreS to final molar ratios [TreS]/[Pep2] of 0, 1, 2, and 4. The coupling reagents were present at these initial concentrations: 4 mM phosphoenolpyruvate, 2 units of pyruvate kinase, 2 units of lactate dehydrogenase, and 0.1 mM NADH.
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